Thanks again for signing up for my exclusive eventcoming up on June 27.
This is going to be big.
Today, I wanted to reveal the secret behind my success as a stock catalyst trader.
Over my 25-year career, I’ve worked as a Trader, a Senior Columnist and a Senior Equity Analyst where I provided exclusive analysis for multi-billion-dollar hedge funds.
It didn’t take long before I became fascinated with the mind-blowing expansion of technology in the biotech field…
Robots performing the work of surgeons…
Tantalizing, yet controversial, stem cell research promising treatments and cures for AIDS, Alzheimer’s and Lou Gehrig’s disease…
And human genome sequencing potentially eliminating Huntington’s disease and cystic fibrosis…
It was amazing to me, the advances that were being made… Ones that would help people live much longer and healthier lives.
As an investment analyst, it was easy to see that biotech was going to be the wave of the future…
And I needed to get in on the ground floor.
So I started digging into everything I could get my hands on.
I quickly landed private, reserved seating for the annual J.P. Morgan Healthcare Conference – considered by many to be the Super Bowl of investing conferences.
This is where thousands of top biotech execs, analysts, fund managers and investment bankers gather for the most critical meeting of the year.
And I began meticulously digging through all the data… developing a set of signals that tells me when biotech stocks will take off.
These signals ended up leading me to what I see now – perhaps the greatest investment opportunity of my generation.
But before I got here, there were other successes for myself and members of my various research services throughout the years……
One exclusive interview with a biotech exec at the conference led to 138% gains for my readers on Astex Pharmaceuticals in 6 months.
Then there was the time I was tracking the latest developments of Auxilium Pharmaceuticals.
It was on the verge of releasing the first new drug in years to treat ED in men.
Auxilium clearly signaled it was a “Buy!”
So I pounded the table, urging my readers to get in.
Now, this wasn’t a popular call… Auxilium’s stock had been “treading water” for several years.
But sure enough…
A jolt in the share price!
My followers at the time were blown away by the lightning-fast gains.
For years now, I’ve devoted my studies to pinpointing the precise events that inevitably drive biotech stocks higher.
That’s why the companies I recommend are virtually predetermined to succeed.
What’s more, these catalyst-driven opportunities aren’t just limited to biotech stocks…
Like the 105% gain I uncovered in 6 weeks on an insurance company.
And the 158% winner in about 3 months on Hartford Financial Services Group.
And another 93% on Mastercard in 6 months.
What I’ve created is a system for uncovering these situations… predictable events that propel stocks to explosive revenue growth… and create bursts in the stock price.
First, I look for companies that are, frankly, good businesses.
I’ve found a few characteristics that all great biotechs share…
- Great management
- New breakthrough products in the pipeline
- A huge market of potential customers
- A head start on their competition
- And several sentiment and technical indicators.
And once I’ve used these factors to narrow down my list, that’s when I look for the special catalyst…
It’s this moment, when the catalyst comes together with all these other positive factors… that’s when the magic happens.
All the elements are there for a huge stock run-up. It just requires that one spark to set things off.
And the spark I see coming up for Nvidia’s biotech is like NOTHING I’ve seen before.
On June 27 at 2 p.m. ET, I’m blowing the lid wide open on this opportunity.
If you haven’t already, please add it to your calendar now:
Add event to calendar
Tomorrow, keep an eye on your inbox for a message from George Rayburn… the host of our upcoming special event.
And if you have a moment, please drop me an email to let me know what YOU hope to get out of this event.
We’re getting close now and I couldn’t be more excited. See you soon!
Good investing,
Marc
P.S. I urge you again to click here and sign up for free VIP text messaging because it’s such a great resource.
By becoming a VIP, you’ll also receive a complimentary VIP report. (You’ll get it instantly, sent to both your phone and your computer.)
It’s called, “5 Secrets for Investing in the AI Biotech Boom.“
P.P.S. You can also follow along with this whole series at…
You can find every article there, so you won’t ever miss an update.
I’ll see you on June 27!